# Post Mastectomy Hypofractionated Radiotherapy in High Risk Breast Cancer

> **NCT03319069** · PHASE3 · UNKNOWN · sponsor: **Ahmed Ahm** · enrollment: 60 (estimated)

## Conditions studied

- Breast Cancer

## Interventions

- **RADIATION:** Hypofractionated radiotherapy
- **RADIATION:** Conventional fractionated radiotherapy

## Key facts

- **NCT ID:** NCT03319069
- **Lead sponsor:** Ahmed Ahm
- **Sponsor class:** OTHER
- **Phase:** PHASE3
- **Study type:** INTERVENTIONAL
- **Status:** UNKNOWN
- **Start date:** 2017-10-01
- **Primary completion:** 2018-09-01
- **Final completion:** 2019-09-01
- **Target enrollment:** 60 (ESTIMATED)
- **Last updated:** 2017-10-24


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT03319069

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT03319069, "Post Mastectomy Hypofractionated Radiotherapy in High Risk Breast Cancer". Retrieved via AI Analytics 2026-05-26 from https://api.ai-analytics.org/clinical/NCT03319069. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*